Vladislav Zarayskiy

Vladislav Zarayskiy is the Director of Automation & Screening at Monte Rosa Therapeutics. Vladislav has over eight years of experience in the pharmaceutical industry, with a focus on target identification and validation, high throughput screening, and assay development.

Previously, Zarayskiy was a Principal Scientist at Jnana Therapeutics, where they worked on target identification and validation, high throughput screening, and assay development for oncology projects. Prior to that, they were a Senior Scientist at FORMA Therapeutics, Inc., where they worked on signaling and phenotypic screening for pepducins - allosteric peptide modulators of GPCRs’ activities - targeted at a molecule important for angiogenesis and tumor microenviroment.

Zarayskiy received their PhD in molecular and cellular biology from the University of Massachusetts Amherst.

Dr. Vladislav Zarayskiy is a biophysicist who received their Ph.D. from University at Buffalo. Vladislav also holds a B.Sc. in biology from Indiana University Bloomington and a degree in biology from Lomonosov Moscow State University (MSU).

They work with Jennifer Champoux - SVP, Operations, Jullian G. Jones - SVP, Head of Business Development. Vladislav Zarayskiy reports to Min Wang, COO.